Tyra Biosciences Inc - הכנסה לפני ניכוי ריבית, מסים ופחת TYRA
Management's expertise in molecular modeling drives the upward trend, where EBITDA demonstrates growth dynamics. This is supported by the SNAP platform for combating resistance and massive demand for next-generation inhibitors. The value of 0.00 reflects the latest metric value, capturing the current financial result of the commercial activities of Tyra Biosciences, Inc. (TYRA).
Tyra Biosciences (TYRA) - פילוחי מדדים ודוחות פיננסיים
The indicator is calculated as daily cash flow from operating activities, adjusted for non-cash charges and interest. This metric provides continuous monitoring of operational efficiency between quarterly reports, eliminating the risk of sudden drawdowns. For Tyra Biosciences, Inc. (TYRA), this is a critical tool for controlling R&D costs during the development of FGFR inhibitors. By analyzing the EBITDA_Co trend on the GURU.Markets platform, investors can assess the capital burn rate ahead of key FDA milestones.
